A malaria vaccine with live parasites shows promise in a small trial

In a one-two punch, a malaria vaccine in development pairs a shot of the live parasite that causes the disease with a whammy of infection-fighting drugs to immediately quell it.

The candidate is the latest vaccine to show promise against a formidable foe, bolstering hopes that an effective shot might be on the horizon. Malaria, a disease caused by the parasite Plasmodium falciparum, affects more than 200 million people around the world every year. In 2019, an estimated 409,000 people died from the mosquito-borne disease, 67 percent of whom were children younger than 5.

The live parasite vaccine and drug combo showed 87.5 percent efficacy in a small group

→ Continue reading at Science News

More from author

Related posts


Latest posts

Didi gets hit by Chinese government, and Pleo raises $150M

Hello and welcome back to Equity, TechCrunch’s venture-capital-focused podcast where we unpack the numbers behind the headlines. This is Equity Monday Tuesday, our weekly kickoff...

Roblox partners with Sony Music to connect artists with money-making activities in the metaverse

Video game platform Roblox announced this morning it has partnered with Sony Music Entertainment on a deal that will allow the two companies to...

Italy’s DPA fines Glovo-owned Foodinho $3M, orders changes to algorithmic management of riders

Algorithmic management of gig workers has landed Glovo-owned on-demand delivery firm Foodinho in trouble in Italy where the country’s data protection authority issued a...